![Topical sirolimus for the treatment of angiofibromas in tuberous sclerosis - Indian Journal of Dermatology, Venereology and Leprology Topical sirolimus for the treatment of angiofibromas in tuberous sclerosis - Indian Journal of Dermatology, Venereology and Leprology](https://ijdvl.com/content/126/2017/83/1/Images/ijdvl_2017_83_1_27_190844_f1.jpg)
Topical sirolimus for the treatment of angiofibromas in tuberous sclerosis - Indian Journal of Dermatology, Venereology and Leprology
![Topical mTOR (mechanistic target of rapamycin) inhibitor therapy in facial angiofibroma - Indian Journal of Dermatology, Venereology and Leprology Topical mTOR (mechanistic target of rapamycin) inhibitor therapy in facial angiofibroma - Indian Journal of Dermatology, Venereology and Leprology](https://ijdvl.com/content/126/2015/81/5/Images/ijdvl_2015_81_5_540_163800_u1.jpg)
Topical mTOR (mechanistic target of rapamycin) inhibitor therapy in facial angiofibroma - Indian Journal of Dermatology, Venereology and Leprology
![Topical sirolimus 0.1% for treating cutaneous microcystic lymphatic malformations in children and adults (TOPICAL): protocol for a multicenter phase 2, within-person, randomized, double-blind, vehicle-controlled clinical trial | Trials | Full Text Topical sirolimus 0.1% for treating cutaneous microcystic lymphatic malformations in children and adults (TOPICAL): protocol for a multicenter phase 2, within-person, randomized, double-blind, vehicle-controlled clinical trial | Trials | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13063-019-3767-8/MediaObjects/13063_2019_3767_Fig1_HTML.png)
Topical sirolimus 0.1% for treating cutaneous microcystic lymphatic malformations in children and adults (TOPICAL): protocol for a multicenter phase 2, within-person, randomized, double-blind, vehicle-controlled clinical trial | Trials | Full Text
![Frontiers | Early Sirolimus Gel Treatment May Diminish Angiofibromas and Prevent Angiofibroma Recurrence in Children With Tuberous Sclerosis Complex Frontiers | Early Sirolimus Gel Treatment May Diminish Angiofibromas and Prevent Angiofibroma Recurrence in Children With Tuberous Sclerosis Complex](https://www.frontiersin.org/files/Articles/490613/fmed-07-00001-HTML/image_m/fmed-07-00001-g002.jpg)
Frontiers | Early Sirolimus Gel Treatment May Diminish Angiofibromas and Prevent Angiofibroma Recurrence in Children With Tuberous Sclerosis Complex
![Topical rapamycin for angiofibromas in patients with tuberous sclerosis: how does it work in clinical practice? Topical rapamycin for angiofibromas in patients with tuberous sclerosis: how does it work in clinical practice?](https://oaepublishstorage.blob.core.windows.net/c6867204-8610-42bb-b49c-9de48bb061c6/1785.fig.7.png)
Topical rapamycin for angiofibromas in patients with tuberous sclerosis: how does it work in clinical practice?
Efficacy and Safety of Topical Sirolimus Therapy for Facial Angiofibromas in the Tuberous Sclerosis Complex : A Randomized Clini
![Buy Rapalimus gel 0.2% from Japan for skin lesions in tuberous sclerosis ( sirolimus, rapamycin) online at discounted price. - Japan Health Center Buy Rapalimus gel 0.2% from Japan for skin lesions in tuberous sclerosis ( sirolimus, rapamycin) online at discounted price. - Japan Health Center](https://bio-japan.net/image/cache/data/product/Rapalimus/rapalimus_gel_photo2-500x500.jpg)
Buy Rapalimus gel 0.2% from Japan for skin lesions in tuberous sclerosis ( sirolimus, rapamycin) online at discounted price. - Japan Health Center
![Topical 0.2% Rapamycin to Treat Facial Angiofibromas and Hypomelanotic Macules in Tuberous Sclerosis | Actas Dermo-Sifiliográficas Topical 0.2% Rapamycin to Treat Facial Angiofibromas and Hypomelanotic Macules in Tuberous Sclerosis | Actas Dermo-Sifiliográficas](https://multimedia.elsevier.es/PublicationsMultimediaV1/file//15782190/0000010500000008/v1_201409260034/S1578219014002017/v1_201409260034/en/main.assets/gr1.jpeg?xkr=ue/ImdikoIMrsJoerZ+w91sAmkCw32Jed9sZf6jzEuDbFpW7G0NfARZs8afh+9K8v8RN+oFy2ZmalFHXVYo6Aq+/+tYSfrJHoIjA0ZsKBCmTzTtPJCcLdztuyjMF+NvJ9rOIL9Y+3V5/XfdcvEtaejTmkMV0R+wZIk5v8PqBgthSmEM1WnAJoNW3GtJYI95soZCcpEJ1372kM0WosVeLhQcqEjA06aDEU9GHrbrt4EXM5aMgZuqdHaJDcgylF84YlHtjSHZqroY1BCh5yJ8psumHNOyNteye23LW45Bsyxg=)
Topical 0.2% Rapamycin to Treat Facial Angiofibromas and Hypomelanotic Macules in Tuberous Sclerosis | Actas Dermo-Sifiliográficas
![Safety and Efficacy of the Sirolimus Gel for TSC Patients With Facial Skin Lesions in a Long-Term, Open-Label, Extension, Uncontrolled Clinical Trial | Dermatology and Therapy Safety and Efficacy of the Sirolimus Gel for TSC Patients With Facial Skin Lesions in a Long-Term, Open-Label, Extension, Uncontrolled Clinical Trial | Dermatology and Therapy](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs13555-020-00387-7/MediaObjects/13555_2020_387_Fig5_HTML.jpg)
Safety and Efficacy of the Sirolimus Gel for TSC Patients With Facial Skin Lesions in a Long-Term, Open-Label, Extension, Uncontrolled Clinical Trial | Dermatology and Therapy
![Topical rapamycin for angiofibromas in paediatric patients with tuberous sclerosis: Follow up of a pilot study and promising future directions - Tu - 2014 - Australasian Journal of Dermatology - Wiley Online Library Topical rapamycin for angiofibromas in paediatric patients with tuberous sclerosis: Follow up of a pilot study and promising future directions - Tu - 2014 - Australasian Journal of Dermatology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/c4247e05-e9a3-46c5-a9b5-2484be098f55/ajd12125-fig-0004-m.jpg)
Topical rapamycin for angiofibromas in paediatric patients with tuberous sclerosis: Follow up of a pilot study and promising future directions - Tu - 2014 - Australasian Journal of Dermatology - Wiley Online Library
![Long‐term treatment of cutaneous manifestations of tuberous sclerosis complex with topical 1% sirolimus cream: A prospective study of 25 patients | Semantic Scholar Long‐term treatment of cutaneous manifestations of tuberous sclerosis complex with topical 1% sirolimus cream: A prospective study of 25 patients | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/42346552f5fb5eb83b3386cef541443eb162028d/7-Figure4-1.png)